Shanxi Zhendong Pharmaceutical Co Ltd Class A 300158
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CNY 4.62
- Day Range
- CNY 4.61–4.73
- 52-Week Range
- CNY 3.62–8.47
- Bid/Ask
- CNY 4.69 / CNY 4.70
- Market Cap
- CNY 4.83 Bil
- Volume/Avg
- 26.7 Mil / 26.7 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 1.41
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Shanxi Zhendong Pharmaceutical Co Ltd together with its subsidiaries, researches, develops, manufactures, and markets pharmaceutical products and Chinese medicines in China. It offers anticancer drugs, cardiovascular disease prevention and control drugs and anti-infection drugs among others. The company categorizes its product as Chinese & Western Medicine, Wuhe Food, Home Care Products and Traditional Chinese Medicine.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 3,576
- Website
- http://en.zdjt.com
Comparables
Valuation
|
Metric
|
300158
|
000590
|
300016
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | — |
Price/Book Value | 0.94 | 2.16 | 1.46 |
Price/Sales | 1.41 | 4.05 | 2.63 |
Price/Cash Flow | — | — | 41.36 |
Price/Earnings
300158
000590
300016
Financial Strength
|
Metric
|
300158
|
000590
|
300016
|
|---|---|---|---|
Quick Ratio | 3.75 | 1.50 | 2.84 |
Current Ratio | 5.34 | 2.08 | 3.76 |
Interest Coverage | −24.55 | 3.71 | −0.39 |
Quick Ratio
300158
000590
300016
Profitability
|
Metric
|
300158
|
000590
|
300016
|
|---|---|---|---|
Return on Assets (Normalized) | −1.73% | −1.66% | −2.34% |
Return on Equity (Normalized) | −2.06% | −2.67% | −3.88% |
Return on Invested Capital (Normalized) | −2.23% | −2.13% | −1.18% |
Return on Assets
300158
000590
300016
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Dhncpkkh | Cjs | $72.4 Bil | |
MKKGY
| Merck KGaA ADR | Jyjqlpffh | Knspygx | $69.1 Bil | |
HLN
| Haleon PLC ADR | Khgnzgkc | Kvl | $37.8 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Zmyrkstqt | Gbbh | $15.7 Bil | |
VTRS
| Viatris Inc | Cjbnkrwj | Ytrtc | $13.8 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Rdlxfppv | Mlrgd | $12.4 Bil | |
CTLT
| Catalent Inc | Bqmqrkwd | Pmchxpp | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Nlbpsmzt | Swty | $4.5 Bil | |
CURLF
| Curaleaf Holdings Inc | Hhxgxksr | Rnfh | $4.1 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Vphptjxdf | Jzcsd | $3.5 Bil |